Effect of carbenoxolone sodium on human gastric acid secretion.
Neither basal nor peak acid output changed significantly after treatment for four weeks with carbenoxolone sodium as Biogastrone tablets in patients with gastric ulcer or Duogastrone capsules in patients with duodenal ulcer.
D002229:Carbenoxolone / Q000494:pharmacology*; D004381:Duodenal Ulcer / Q000503:physiopathology*; D005750:Gastric Juice / Q000378:metabolism*; D006801:Humans; D012636:Secretory Rate / Q000187:drug effects; D013276:Stomach Ulcer / Q000503:physiopathology*; D014315:Triterpenes / Q000494:pharmacology*
D014315:Triterpenes; D002229:Carbenoxolone